Contineum Therapeutics Investor Relations Material
Latest events
Q1 2025
14 May, 2025
Q4 2024
6 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Contineum Therapeutics Inc
Access all reports
Contineum Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel, oral small molecule therapies. The company focuses on treatments for neuroscience, inflammation, and immunology (NI&I) conditions that have significant unmet medical needs. Contineum is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Contineum Therapeutics Inc
Q1 2025
Contineum Therapeutics Inc
Q1 2025
Contineum Therapeutics Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CTNM
Country
🇺🇸 United States